Cullinan Therapeutics (CGEM) Interest Coverage Ratio (2020 - 2026)
Cullinan Therapeutics' (CGEM) quarterly Interest Coverage Ratio came in at 19.5 in Q1 2026, up 89.54% year-on-year from 10.29 in Q1 2025, and up 99.68% quarter-over-quarter from 6139.89 in Q4 2025.
Cullinan Therapeutics (CGEM) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Cullinan Therapeutics' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 19.5 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 89.54% year-over-year to 19.5 in Q1 2026; TTM through Mar 2026 was 87.3, a 87.67% increase from a year earlier, with the FY2025 full-year figure at 23.54, down 1465.18% from the prior year.
- Interest Coverage Ratio advanced to 19.5 in Q1 2026 per CGEM's latest filing, from 6139.89 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 65.97 in Q2 2022 and bottomed at 6139.89 in Q4 2025.
- The 5-year median for Interest Coverage Ratio is 12.08 (2024), against an average of 415.5.
- Across the five-year window, Interest Coverage Ratio soared 124404.83% in 2022 and plunged 1460354.35% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 0.7 in 2022, then rose by 25.34% to 0.52 in 2023, then advanced by 19.24% to 0.42 in 2024, then plunged by 1460354.35% to 6139.89 in 2025, then soared by 99.68% to 19.5 in 2026.
- Per Business Quant, the three latest CGEM Interest Coverage Ratio figures stand at 19.5 (Q1 2026), 6139.89 (Q4 2025), and 44.91 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Cullinan Therapeutics | 368.65 Mn | 368.65 Mn | - | -19.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.50 |
| Dec 31, 2025 | -6,139.89 |
| Sep 30, 2025 | -44.91 |
| Jun 30, 2025 | -430.67 |
| Mar 31, 2025 | -186.43 |
| Dec 31, 2024 | -0.42 |
| Sep 30, 2024 | -201.05 |
| Jun 30, 2024 | -16.42 |
| Mar 31, 2024 | -12.08 |
| Dec 31, 2023 | -0.52 |
| Sep 30, 2023 | -42.48 |
| Jun 30, 2023 | -7.41 |
| Mar 31, 2023 | -11.34 |
| Dec 31, 2022 | -0.70 |
| Sep 30, 2022 | -5.17 |
| Jun 30, 2022 | 65.97 |
| Mar 31, 2022 | -10.42 |
| Dec 31, 2021 | -0.77 |
| Sep 30, 2021 | -10.88 |
| Jun 30, 2021 | -0.05 |